Sales of Common Stock
In November 2018, we sold 16,000,000 shares of our Class A common stock to one accredited investor at a purchase price of $6.03 per share, for an aggregate purchase price of $96.5 million.
In February 2019, we sold 16,583,747 shares of our Class A common stock to one accredited investor at a purchase price of $6.03 per share, for an aggregate purchase price of $100.0 million.
From April 2020 through July 2020, we sold an aggregate of 206,500,523 shares of our Class A common stock to 59 accredited investors at a purchase price of $4.65 per share, for an aggregate purchase price of $960.2 million.
Plan-Related Issuances
Between July 1, 2017 and September 14, 2020, we have granted to our employees, consultants, and other service providers options to purchase an aggregate of 57,380,627 shares of our Class B common stock under our 2010 Amended Equity Incentive Plan, or our 2010 Plan, at exercise prices ranging from $4.72 to $6.03 per share.
Between July 1, 2017 and September 14, 2020, we have granted to our employees, consultants, and other service providers options to purchase an aggregate of 470,502,521 shares of our Class A common stock under our 2010 Plan, at exercise prices ranging from $4.72 to $7.40 per share.
Between July 1, 2017 and September 14, 2020, we have issued and sold to our employees, consultants, and other service providers an aggregate of 32,664,972 shares of our Class B common stock upon the exercise of stock options under our 2010 Plan, at exercise prices ranging from $0.85 to $6.13 per share, for an approximate weighted-average exercise price of $1.31 per share.
Between July 1, 2017 and September 14, 2020, we have issued and sold to our employees, consultants, and other service providers an aggregate of 46,493,716 shares of our Class B common stock upon the exercise of stock options under our 2006 Plan, at exercise prices ranging from $0.012 to $0.52 per share, for an approximate weighted-average exercise price of $0.45 per share.
Between July 1, 2017 and September 14, 2020, we have issued and sold to our employees, consultants, and other service providers an aggregate of 26,613,715 shares of our Class A common stock upon the exercise of stock options under our 2010 Plan, at exercise prices ranging from $1.10 to $7.40 per share, for an approximate weighted-average exercise price of $3.28 per share.
Between July 1, 2017 and September 14, 2020, we have granted to our employees, consultants, and other service providers growth units representing an aggregate of 23,113,150 shares of our Class A common stock, under our 2010 Plan. In November 2019, growth units representing 18,498,074 shares of our Class A common stock were amended into restricted stock units, or RSUs, representing an equal number of shares of Class A common stock.
Between July 1, 2017 and September 14, 2020, we have granted to our employees, consultants, and other service providers RSUs representing an aggregate of 199,222,955 shares of our Class A common stock, under our 2010 Plan (which number of RSUs excludes 18,498,074 growth units that were converted into RSUs in November 2019).
Between July 1, 2017 and September 14, 2020, we have granted to our employees, consultants, and other service providers RSUs representing an aggregate of 56,100,000 shares of our Class B common stock under our 2010 Plan and 3,900,000 shares of our Class B common stock under our 2020 Executive Equity Incentive Plan, as well as options representing an aggregate of 162,000,000 shares of our Class B common stock under our 2020 Executive Equity Incentive Plan.
II-3